Technical Analysis for SAVA - Cassava Sciences, Inc.

Grade Last Price % Change Price Change
F 20.74 0.92% 0.19
SAVA closed up 0.92 percent on Wednesday, April 24, 2024, on 62 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Apr 29
*** please verify all earnings dates ***
5 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion 0.92%
Oversold Stochastic Weakness 0.92%
Multiple of Ten Bullish Other 1.17%
Inside Day Range Contraction 1.17%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 16 hours ago
Up 1% about 20 hours ago
Fell Below Previous Day's Low about 20 hours ago
Down 1% about 20 hours ago
60 Minute Opening Range Breakout 2 days ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cassava Sciences, Inc. develops drugs for nervous system disorders in the United States. It engages in developing FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; PTI-125, a small molecule drug candidate to treat Alzheimer's disease; and PTI-125DX, a blood-based diagnostic/biomarker to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was founded in 1998 and is based in Austin, Texas.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Pain Neuroscience Alzheimer's Disease Mental Health Biomarkers Psychiatric Diagnosis Psychiatry Nervous System Disorders Transdermal Abnormal Psychology

Is SAVA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 32.1
52 Week Low 12.3202
Average Volume 775,298
200-Day Moving Average 21.30
50-Day Moving Average 21.58
20-Day Moving Average 21.52
10-Day Moving Average 21.38
Average True Range 1.48
RSI (14) 47.09
ADX 13.8
+DI 21.92
-DI 24.82
Chandelier Exit (Long, 3 ATRs) 22.23
Chandelier Exit (Short, 3 ATRs) 23.88
Upper Bollinger Bands 25.24
Lower Bollinger Band 17.80
Percent B (%b) 0.4
BandWidth 34.56
MACD Line -0.25
MACD Signal Line -0.05
MACD Histogram -0.1965
Fundamentals Value
Market Cap 875.99 Million
Num Shares 42.2 Million
EPS -2.29
Price-to-Earnings (P/E) Ratio -9.06
Price-to-Sales 0.00
Price-to-Book 6.82
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.75
Resistance 3 (R3) 21.67 21.25 21.58
Resistance 2 (R2) 21.25 21.00 21.29 21.52
Resistance 1 (R1) 21.00 20.84 21.13 21.08 21.47
Pivot Point 20.58 20.58 20.65 20.62 20.58
Support 1 (S1) 20.33 20.33 20.46 20.41 20.01
Support 2 (S2) 19.91 20.17 19.95 19.96
Support 3 (S3) 19.66 19.91 19.90
Support 4 (S4) 19.74